Conference Details - Overview
Continuing Education Information
Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
13th Annual Fall Oncology Conference: Clinical Challenges in Cancer Medicine
The Westin Hilton Head Island
Hilton Head Island, SC
October 2-4, 2009
Conference Overview
Held in Conjunction With the 10th Annual Medical Oncology Fellows Forum
CME- and CNE-Certified Conference
Important advances in the field of oncology over the past several years have led to improvements in outcome for several malignancies and newer treatment options for refractory disease. This has resulted in a need to improve performance in clinical practice through the understanding of how to optimally individualize care based on benefits and risks in specific situations and defined patient populations. The 13th Annual Fall Oncology Conference: Clinical Challenges in Cancer Medicine has been designed to address clinical challenges and practical issues faced each day by community oncologists, oncology nurses, oncology physician’s assistants and other oncology professionals. The conference is intended to inform oncology professionals and fellows in training of the recent data on agents approved for and being evaluated in the most common tumor types, including breast, lung, genitourinary, gastrointestinal, gynecological and hematologic malignancies, and sarcoma. In addition, this activity focuses on providing a thorough understanding of the toxicity profiles of controversial and evolving regimens with hormonal therapy, chemotherapy, and novel targeted agents so as to aid oncology professionals in making effective decisions regarding treatment, management of patients and trial enrollment.
This educational program is directed toward medical, radiation, and surgical oncologists with an interest in recent advances in the treatment of solid tumors as well as hematologic malignancies. Fellows, oncology nurses, oncology physician assistants, and pharmacists are also invited to attend. A portion of this program is directly intended for Hematology/Oncology fellows in training who have been nominated by their program directors from across the country.At the conclusion of this conference, you should be able to:
- Apply diagnostic tests and prognostic markers to treatment decisions for patients with colorectal cancer, NSCLC, and breast cancer
- Summarize the safety and efficacy of new management strategies for patients with solid tumors and hematologic malignancies
- Evaluate management strategies for patients with ITP
- Describe the complications associated with antiangiogenic therapy for patients with solid tumors
- Assess the efficacy and safety of strategies for maintaining bone health in patients with breast cancer
- Identify which clinical trials will best benefit patients with solid tumors and hematologic malignancies
Educational Grants
An educational grant for this activity was provided by:
- AstraZeneca
- Bristol-Myers Squibb
- Celgene Corporation
- sanofi-aventis U.S.